549 related articles for article (PubMed ID: 30038048)
21. The inclusion membrane protein IncS is critical for initiation of the Chlamydia intracellular developmental cycle.
Cortina ME; Bishop RC; DeVasure BA; Coppens I; Derré I
PLoS Pathog; 2022 Sep; 18(9):e1010818. PubMed ID: 36084160
[TBL] [Abstract][Full Text] [Related]
22. Targeted Disruption of Chlamydia trachomatis Invasion by in Trans Expression of Dominant Negative Tarp Effectors.
Parrett CJ; Lenoci RV; Nguyen B; Russell L; Jewett TJ
Front Cell Infect Microbiol; 2016; 6():84. PubMed ID: 27602332
[TBL] [Abstract][Full Text] [Related]
23. Analysis of pmpD expression and PmpD post-translational processing during the life cycle of Chlamydia trachomatis serovars A, D, and L2.
Kiselev AO; Skinner MC; Lampe MF
PLoS One; 2009; 4(4):e5191. PubMed ID: 19367336
[TBL] [Abstract][Full Text] [Related]
24. Tag-Dependent Substrate Selection of ClpX Underlies Secondary Differentiation of Chlamydia trachomatis.
Wood NA; Swoboda AR; Blocker AM; Fisher DJ; Ouellette SP
mBio; 2022 Oct; 13(5):e0185822. PubMed ID: 36154190
[TBL] [Abstract][Full Text] [Related]
25. Sigma 54-Regulated Transcription Is Associated with Membrane Reorganization and Type III Secretion Effectors during Conversion to Infectious Forms of Chlamydia trachomatis.
Soules KR; LaBrie SD; May BH; Hefty PS
mBio; 2020 Sep; 11(5):. PubMed ID: 32900805
[No Abstract] [Full Text] [Related]
26. Differential Effects of Small Molecule Inhibitors on the Intracellular Chlamydia Infection.
Muñoz KJ; Tan M; Sütterlin C
mBio; 2022 Aug; 13(4):e0107622. PubMed ID: 35703434
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of groEL-1, incB, pyk-F, tal, hctA and omcB genes during Chlamydia trachomatis developmental cycle.
Mzobe GF; Ngcapu S; Joubert BC; Sturm WA
PLoS One; 2021; 16(4):e0249358. PubMed ID: 33857160
[TBL] [Abstract][Full Text] [Related]
28. Chlamydia spp. development is differentially altered by treatment with the LpxC inhibitor LPC-011.
Cram ED; Rockey DD; Dolan BP
BMC Microbiol; 2017 Apr; 17(1):98. PubMed ID: 28438125
[TBL] [Abstract][Full Text] [Related]
29. Serotonin and melatonin, neurohormones for homeostasis, as novel inhibitors of infections by the intracellular parasite chlamydia.
Rahman MA; Azuma Y; Fukunaga H; Murakami T; Sugi K; Fukushi H; Miura K; Suzuki H; Shirai M
J Antimicrob Chemother; 2005 Nov; 56(5):861-8. PubMed ID: 16172105
[TBL] [Abstract][Full Text] [Related]
30. A Coming of Age Story: Chlamydia in the Post-Genetic Era.
Hooppaw AJ; Fisher DJ
Infect Immun; 2015 Dec; 84(3):612-21. PubMed ID: 26667838
[TBL] [Abstract][Full Text] [Related]
31. Clinical Persistence of Chlamydia trachomatis Sexually Transmitted Strains Involves Novel Mutations in the Functional αββα Tetramer of the Tryptophan Synthase Operon.
Somboonna N; Ziklo N; Ferrin TE; Hyuk Suh J; Dean D
mBio; 2019 Jul; 10(4):. PubMed ID: 31311884
[TBL] [Abstract][Full Text] [Related]
32. Biochemical and Genetic Analysis of the Chlamydia GroEL Chaperonins.
Illingworth M; Hooppaw AJ; Ruan L; Fisher DJ; Chen L
J Bacteriol; 2017 Jun; 199(12):. PubMed ID: 28396349
[TBL] [Abstract][Full Text] [Related]
33. Effect of 6-thioguanine on Chlamydia trachomatis growth in wild-type and hypoxanthine-guanine phosphoribosyltransferase-deficient cells.
Qin B; McClarty G
J Bacteriol; 1992 May; 174(9):2865-73. PubMed ID: 1569017
[TBL] [Abstract][Full Text] [Related]
34. Type II fatty acid synthesis is essential for the replication of Chlamydia trachomatis.
Yao J; Abdelrahman YM; Robertson RM; Cox JV; Belland RJ; White SW; Rock CO
J Biol Chem; 2014 Aug; 289(32):22365-76. PubMed ID: 24958721
[TBL] [Abstract][Full Text] [Related]
35. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle.
Wolf K; Betts HJ; Chellas-Géry B; Hower S; Linton CN; Fields KA
Mol Microbiol; 2006 Sep; 61(6):1543-55. PubMed ID: 16968227
[TBL] [Abstract][Full Text] [Related]
36. Use of aminoglycoside 3' adenyltransferase as a selection marker for Chlamydia trachomatis intron-mutagenesis and in vivo intron stability.
Lowden NM; Yeruva L; Johnson CM; Bowlin AK; Fisher DJ
BMC Res Notes; 2015 Oct; 8():570. PubMed ID: 26471806
[TBL] [Abstract][Full Text] [Related]
37. Genetic differences in the Chlamydia trachomatis tryptophan synthase alpha-subunit can explain variations in serovar pathogenesis.
Shaw AC; Christiansen G; Roepstorff P; Birkelund S
Microbes Infect; 2000 May; 2(6):581-92. PubMed ID: 10884608
[TBL] [Abstract][Full Text] [Related]
38. Molecular Characterization of the ClpC AAA+ ATPase in the Biology of Chlamydia trachomatis.
Pan S; Jensen AA; Wood NA; Henrichfreise B; Brötz-Oesterhelt H; Fisher DJ; Sass P; Ouellette SP
mBio; 2023 Apr; 14(2):e0007523. PubMed ID: 36975997
[TBL] [Abstract][Full Text] [Related]
39. Tryptophan Operon Diversity Reveals Evolutionary Trends among Geographically Disparate Chlamydia trachomatis Ocular and Urogenital Strains Affecting Tryptophan Repressor and Synthase Function.
Bommana S; Somboonna N; Richards G; Tarazkar M; Dean D
mBio; 2021 May; 12(3):. PubMed ID: 33975934
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic rescue of Chlamydia trachomatis growth in IFN-gamma treated mouse cells by irradiated Chlamydia muridarum.
Nelson DE; Taylor LD; Shannon JG; Whitmire WM; Crane DD; McClarty G; Su H; Kari L; Caldwell HD
Cell Microbiol; 2007 Sep; 9(9):2289-98. PubMed ID: 17501981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]